simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 37;5^{th}-Individual ID 37;5^{th}-Individual ID 37;5^{th}-Individual ID 37;5^{th}-Individual ID 37;;;95^{th}-Individual ID 50;95^{th}-Individual ID 50;95^{th}-Individual ID 50;95^{th}-Individual ID 50;95^{th}-Individual ID 50
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;0.22742570768912;-0.0476058821737822;0.138123073925659;0.26104201635303;-0.958537387766615;;;-0.00718781788224978;-1.06962272745222;-0.0219974264884592;0.0252610419960122;0.328525372824138
;0.217836814922719;-0.0522575095819286;0.137567469868013;0.255926417462653;-1.06654278371406;;;-8.13230051045916;-8.92455570589866;-8.14752578182195;-8.10008778676825;-7.69188827009341
;0.237014600455521;-0.0429542547656359;0.138678677983306;0.266157615243406;-0.850531991819169;;;8.11792487469466;6.78531025099421;8.10353092884503;8.15060987076027;8.34893901574168
;0.999473706177471;0.99717992137406;0.999995207133295;0.999886257747998;0.996253362484499;;;2.64201397781605e-06;0.0589124673458241;2.47417662443405e-05;3.26291106370613e-05;0.00563238310384984
;5.12507064820075e-06;6.36133860413811e-05;4.45330576396186e-09;5.14856758240479e-07;9.74406629778305e-05;;;0.99793044256832;0.694022463928899;0.993666793082165;0.992727053798222;0.904534161873134
